I could access the page for #ASCO22 survivorship posters. My favorites:
Prevalence of frailty for middle-aged and older adults starting a new line of systemic cancer treatment: Is age just a number? 1/4
Pergolotti Ab 12054 P300
patient reported Geriatric Assess similar frailty
Prevalence of frailty for middle-aged and older adults starting a new line of systemic cancer treatment: Is age just a number? 1/4
Pergolotti Ab 12054 P300
patient reported Geriatric Assess similar frailty
2/4 Effects of scalp cooling on hair preservation/hair regrowth in breast cancer therapy Brunner P 339 #ASCO22
50% patients w/taxane monotherapy grade 1 alopecia compared to 17% patients w/ anthracycline-taxane
Drop-out: 13% in CAP / 5% in NCAP group
No sig effect in regrowth
50% patients w/taxane monotherapy grade 1 alopecia compared to 17% patients w/ anthracycline-taxane
Drop-out: 13% in CAP / 5% in NCAP group
No sig effect in regrowth
3/4 #ASCO22 Yoga intervention on distress indicators among diverse women /gyn , gi, &thoracic cancers Hanvey AB 12129
Mindfulness-based yoga intervention was associated with sig reductions in depressive symptoms, anxiety, & psychological distress related to Fear of Recurrence
Mindfulness-based yoga intervention was associated with sig reductions in depressive symptoms, anxiety, & psychological distress related to Fear of Recurrence
4/4 #ASCO22 A randomized phase III clinical trial of acupuncture for chemotherapy-induced peripheral neuropathy (CIPN) in cancer survivors.
Dooley Ab TPS12125
electroacupunture (EA) versus sham acupuncture (SA)
Accrual completion 2024
Clinical trial information: NCT04917796.
Dooley Ab TPS12125
electroacupunture (EA) versus sham acupuncture (SA)
Accrual completion 2024
Clinical trial information: NCT04917796.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
